Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering. - Wikidata - wikimedia - TriplyDB

Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.

Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.

http://www.wikidata.org/entity/Q36428933

about

Vascular Ageing and Exercise: Focus on Cellular Reparative Processes MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities Chemokines and their receptors in Atherosclerosis Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression Bone marrow endothelial progenitors in atherosclerotic plaque resolution Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(-/-) Mice Induced by Hyperlipaemia The Effect of Granulocyte Colony-Stimulating Factor on the Progression of Atherosclerosis in Animal Models: A Meta-Analysis.Biomimicking Robust Hydrogel for the Mesenchymal Stem Cell Carrier.Differential characteristics and in vitro angiogenesis of bone marrow- and peripheral blood-derived endothelial progenitor cells: evidence from avian species.Noninvasive evaluation of the migration effect of transplanted endothelial progenitor cells in ischemic muscle using a multimodal imaging agent.Loss of the Liver X Receptors Disrupts the Balance of Hematopoietic Populations, With Detrimental Effects on Endothelial Progenitor Cells.Hypermethylation of the Micro-RNA 145 Promoter Is the Key Regulator for NLRP3 Inflammasome-Induced Activation and Plaque Formation

P2860

Q26772296-5D7681EE-3C4C-4F74-8632-84CE1C221A35 Q26800135-437759F0-16E2-458B-B9AF-6BA3BFCE4295 Q26801787-3B48D4CF-56AF-465B-A024-3FEF2976A303 Q33800362-05ED3945-75E1-4A29-8EE6-4C7F4F401A03 Q35503935-76369297-5B68-448B-9C0C-A06492D8F471 Q35784424-D6460182-6642-4566-8F3F-3CAB088101C6 Q36906139-B8EA5B0A-551B-427C-B11D-DFB1C9B34EC8 Q37704741-25447D62-5A1E-408D-BCD9-EA36A757E59F Q38223391-9A8079E5-A238-41EC-ACC2-88AD8A1B2D38 Q41444735-BD191EF3-24A3-4DAF-9535-DCF704EC5118 Q43375962-BF187808-BEB8-4D73-A952-59BFD8BDCC7C Q46737735-27DAF49B-0481-4356-8292-CC99A59F78E6 Q46894577-CFB9D4EE-E21D-4393-B668-2B488007B70E Q55285777-17E13083-5152-4103-833B-0E37EF77B3CE Q55449346-8CAC7B8C-9A0D-4243-A752-CF31A9A88EAB Q59129591-885C2956-4F39-4F88-8371-A8CB4D900580

P2860

Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.

http://www.wikidata.org/entity/Q36428933

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@ast

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@en

type

label

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@ast

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@en

prefLabel

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@ast

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@en

P1433

Q36428933-C68527BF-6020-4BC9-892F-AA92725E28AB

P1476

Q36428933-183273AB-8B36-4A1C-B732-B808DF4B48B9

P2093

Q36428933-1D429424-3A9C-4801-A726-1ADE58AED4B6

Q36428933-457B6A22-AAE5-435B-91F5-4A3265FA0EF5

Q36428933-706F6C20-EC79-49D2-B568-5DE3DA2C9765

Q36428933-A47836B2-498F-4A6D-9ADA-42782F6E3B2E

Q36428933-AF26F42F-1C99-41B5-AB02-003A84EC23A4

Q36428933-B56C6551-BBAD-42F5-8526-3B9086F956C9

Q36428933-B835B95D-9088-4A8D-A0CB-5EA2F78B600E

P2860

Q36428933-03D21B9D-3E5B-446E-B24A-9F60FF079D4A

Q36428933-090A031A-9AC5-44F6-BECF-09336EE363FE

Q36428933-0992D30F-FEB0-494B-876B-159FDCE033A1

Q36428933-0C938C6A-FB55-4FF5-9EB4-223B85ED74D7

Q36428933-13ADDE95-3050-404D-BF3C-ED90358CA8E4

Q36428933-14347BE4-43B0-40EE-88D7-E3849BED1312

Q36428933-151268EE-68FE-49DF-A817-A4A6270C6A06

Q36428933-1A19ABE3-C41E-4D4F-9B4A-51692508FFEB

Q36428933-1F0A1987-BDDC-400E-A8DC-A9A018337CBA

Q36428933-1FAA62CD-1541-4105-9DF4-6D4603741B4A

P304

Q36428933-7F55DF8A-AA14-4EE4-A408-5D039AF75769

P31

Q36428933-92EC0E31-17A3-4F8F-8C1D-86505BE836A6

P356

Q36428933-6566698B-1951-423C-ACAD-EACC9E96D19F

P433

Q36428933-631D5FAF-F0F1-457B-BE5F-BA8D3B6B0FAC

P478

Q36428933-07BAA9DE-1FD4-4785-B028-F802F61A2A59

P577

Q36428933-17CE443C-9361-474F-9B63-24AB3AC094A0

P5875

Q36428933-0A611D13-1C9A-48C3-8C25-ABE2C1113814

P698

Q36428933-67B33926-565E-42EB-84B8-D73D95A5E7C0

P921

Q36428933-35427B29-2053-45A5-B7F7-AD41787296C5

Q36428933-47C31C27-0F52-4487-BA28-E4F1BA004A5E

P932

Q36428933-CDD356F5-F182-4EBC-8E1D-4EACF9E859A7

P356

P1433

P1476

Bone marrow endothelial progen ...... odel of plasma lipid lowering.

@en

P2093

Jana Barlic-Dicen

http://www.w3.org/2001/XMLSchema#string

Janet Heuser-Baker

http://www.w3.org/2001/XMLSchema#string

Longbiao Yao

http://www.w3.org/2001/XMLSchema#string

Ming-Hui Zou

http://www.w3.org/2001/XMLSchema#string

Oana Herlea-Pana

http://www.w3.org/2001/XMLSchema#string

Qilong Wang

http://www.w3.org/2001/XMLSchema#string

Ryuji Iida

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial progenitor cells: what use for the cardiologist?

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system

Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury

Endothelial progenitor cells in cardiovascular disorders

Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

Nitric oxide metabolism and breakdown.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction

Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study.

P304

2720-2731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1256

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232321045

http://www.w3.org/2001/XMLSchema#string

P698

23081735

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3508339

http://www.w3.org/2001/XMLSchema#string